Evaluating the Right Modalities to Deliver Gene Therapy at Scale in Common Diseases
- Comparing gene therapy to small molecules and biologics in terms of tractability and therapeutic reach
- Investigating whether advanced modalities like AAV, mRNA, or LNPs can meet the demands of high-prevalence diseases
- Delving into use cases to understand where gene therapy may offer unique value or face limitations